Gov’t will maintain criteria for KIPC recertifications
By Lee, Jeong-Hwan | translator Kang, Shin-Kook
24.06.05 05:49:43
가나다라
0
Companies continue to request the number of administrative dispositions and the amount set for cancellation of certifications
MOHW announces recertification results of 28 innovative companies in June
Industry "Innovative Pharmaceutical Company Certification cancellation rebate criteria are too excessive"
The government has decided to maintain the recertification process and criteria for Korea Innovative Pharmaceutical Companies.
Therefore, the government decided not to accept the demands of some in the pharmaceutical industry on easing the decertification regulations, ‘2 or more rebate detections and administrative disposition’, and the 'total rebate amount that exceeds KRW 5 million’ regulations.
Based on the maintained regulations, pharmaceutical companies that fall under the current disqualification criteria for innovative pharmaceutical companies, such as the rebate detection regulation, are expected to fail recertifications.
On the 3rd, an official from the
Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)